Immunizing the world’s children against infectious diseases has dramatically cut childhood death and suffering in recent decades. In 2010, philanthropists Bill and Melinda Gates called for a new “Decade of Vaccines” to vault the progress dramatically forward.
The June 2011 issue of Health Affairs, sponsored by the Gates Foundation, examines the strategies that will be needed to achieve the goal. These include making advances in basic vaccine science; devoting more money and other resources to developing vaccines for neglected diseases, such as those like hookworm infections that afflict the world’s poorest people; helping to finance the rollout of critical new vaccines for conditions such as pneumonia and rotavirus; and fostering new product development partnerships that bring pharmaceutical companies, global funders and others together to make new vaccines possible.
At a Health Affairs briefing on June 9, global health leaders and health policy experts will discuss these strategies and the papers in the new issue that address them.
WHEN:………….Thursday, June 9, 2011,
……………………..8:30 a.m. to 1:30 p.m.
WHERE:………..W Hotel Washington
……………………..515 15th Street NW
RSVP:…………..RSVP this event online
Experts will address:
- The estimated benefits of vaccines in terms of lives saved, treatment expenses avoided and economic benefits gained
- Examples of product development partnerships and financing models that have effectively spurred research, development and deployment of vaccines
- How global “supply chains” could be improved to enhance the distribution of vaccines and make it more cost-efficient
- U.S. patients’ perceptions – and misperceptions – about the safety of vaccines
- Nicole Bates, Senior Program Officer, Global Health Policy and Advocacy, Bill & Melinda Gates Foundation
- Orin S. Levine, Associate Professor, Johns Hopkins Bloomberg School of Public Health, and Executive Director, PneumoADIP
- Meghan Stack, Research Associate, Johns Hopkins Bloomberg School of Public Health
- David Bishai, Professor, Johns Hopkins Bloomberg School of Public Health
- Bruce Lee, Assistant Professor of Medicine, Epidemiology, and Biomedical Informatics at the University of Pittsburgh School of Medicine and Graduate School of Public Health
- Roger Miller, LMI Government Consulting
- Christopher Snyder, Professor, Department of Economics, Dartmouth College
- Glen Nowak, Senior Advisor to Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control
- Lewellys Barker, Senior Medical Advisor and Director of Policy, Aeras Global TB Vaccine Foundation
- Peter Hotez, President, Sabin Vaccine Institute
- Ramanan Laxminarayan, Director, Center for Disease Dynamics, Economics & Policy
Routine vaccination has saved the lives of 20 million children in the developing world over the last two decades. Up to 80 percent of eligible children are currently being immunized with vaccines against basic childhood diseases and increasingly against deadly causes of diarrhea, pneumonia, and meningitis. However, each year 2.4 million child deaths occur that could have been prevented through immunization. Creative product development and financing models, such as private-public partnerships, have been critical in boosting vaccine development. Recent examples include the new meningitis A vaccine which, at less than 50 cents per dose, has been distributed to more than 19 million residents of the hardest hits regions of Africa.
Vaccines against deadly diseases such as malaria and tuberculosis are within 3-5 years of entering the market, but increased government and private sector investment are needed to ensure that the new technologies will live up to their promise.
If you have any questions about this event, please contact Morgan Warners, Burness Communications, at 301-652-1558 or email@example.com.Email This Post Print This Post